Hon ANDREW LITTLE: The key benefit we are focusing on for this research is how lessons from the response to the COVID-19 pandemic can be brought to bear on future responses and mass vaccine roll-outs. We'd also expect that equity should be a key element of any proposal. It's become clear that systemic inequities in access to healthcare existed in the system and played out during the course of our response to COVID. This is why one of the criterion for assessments of research proposals will be how rapidly the evidence can be translated into practice or interventions in New Zealand and for our underserved communities, particularly Māori.